TickerLeague

Cash on Hand for ResMed (RMD)

According to ResMed's latest reported financial statements, the company's latest reported cash and short-term investments is $1.43B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$1.43B

YoY change

+407.4%

5Y CAGR

+21.2%

Peak year (2025)

$1.21B

Latest annual

$1.21B

Cash on Hand history chart for ResMed (RMD) from 1993 to 2025

Cash on Hand history table for ResMed (RMD) from 1993 to 2025

Fiscal yearPeriod endedReportedCash on HandYoY
2025$1.21B+407.4%
2024$238.36M+4.6%
2023$227.89M-16.7%
2022$273.71M-7.3%
2021$295.28M-36.2%
2020$463.16M+214.8%
2019$147.13M-22.0%
2018$188.70M-77.0%
2017$821.93M+12.4%
2016$731.43M+2.0%
2015$717.25M-20.8%
2014$905.73M+3.4%
2013$876.05M+8.2%
2012$809.54M+10.1%
2011$735.27M+50.4%
2010$488.78M+17.6%
2009$415.65M+29.5%
2008$321.08M+15.6%
2007$277.74M+26.5%
2006$219.54M+54.4%
2005$142.19M+0.9%
2004$140.93M+16.4%
2003$121.02M+30.4%
2002$92.84M-9.6%
2001$102.75M+367.8%
2000$21.96M+31.5%
1999$16.70M+7.7%
1998$15.50M+70.3%
1997$9.10M+65.5%
1996$5.50M+66.7%
1995$3.30M-10.8%
1994$3.70M+117.6%
1993$1.70M

Cash on Hand values are taken from ResMed's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

ResMed (RMD) most recent annual cash and short-term investments stands at $1.21B (2025) – surged 407.4% year-over-year.

Looking at the 2020–2025 (5 years) stretch, ResMed cash and short-term investments compounded at +21.2% per year, sustaining 2 straight years of year-over-year growth.

Across the available history, cash and short-term investments reached its high of $1.21B in 2025 and its low of $1.70M in 1993.

Within Healthcare, ResMed (RMD) ranks 9th among 8 peers we track. The peer median for cash and short-term investments is $11.85B.

ResMed Cash on Hand by Year

ResMed Cash on Hand 2025: $1.21B

ResMed cash and short-term investments in 2025 was $1.21B, surged 407.4% from 2024. This figure represents the highest annual value in the available history.

ResMed Cash on Hand 2024: $238.36M

ResMed cash and short-term investments in 2024 was $238.36M, edged up 4.6% from 2023.

ResMed Cash on Hand 2023: $227.89M

ResMed cash and short-term investments in 2023 was $227.89M, declined 16.7% below 2022.

ResMed Cash on Hand 2022: $273.71M

ResMed cash and short-term investments in 2022 was $273.71M, declined 7.3% below 2021.

ResMed Cash on Hand 2021: $295.28M

ResMed cash and short-term investments in 2021 was $295.28M.

See more financial history for ResMed (RMD).

Sector peers — Cash on Hand

Companies in the same sector as ResMed, ranked by their latest cash and short-term investments.

CompanyCash on HandSector
UnitedHealth Group Incorporated (UNH)$28.12BHealthcare
Novo Nordisk A/S (NVO)$26.96BHealthcare
Johnson & Johnson (JNJ)$20.10BHealthcare
Merck & Co., Inc. (MRK)$14.56BHealthcare
Amgen Inc. (AMGN)$9.13BHealthcare
Eli Lilly and Company (LLY)$7.27BHealthcare
AstraZeneca PLC (AZN)$5.74BHealthcare
AbbVie Inc. (ABBV)$5.26BHealthcare

Frequently asked questions

What is ResMed's cash and short-term investments?

Latest reported cash and short-term investments for ResMed (RMD) is $1.43B (period ending December 31, 2025).

How has ResMed cash and short-term investments changed year-over-year?

ResMed (RMD) cash and short-term investments changed +407.4% year-over-year on the latest annual filing.

What is the long-term growth rate of ResMed cash and short-term investments?

ResMed (RMD) cash and short-term investments compound annual growth rate is +21.2% over the most recent 5 years available.

When did ResMed cash and short-term investments hit its highest annual value?

ResMed cash and short-term investments reached its highest annual value of $1.21B in 2025.

What was ResMed cash and short-term investments in 2024?

ResMed (RMD) cash and short-term investments in 2024 was $238.36M.

What was ResMed cash and short-term investments in 2025?

ResMed (RMD) cash and short-term investments in 2025 was $1.21B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.